Archive for March 5, 2010

“Tunnel Anxiety” Can Be Reduced

Many people feel insecure when they drive in tunnels. However, their anxiety can be reduced. “Driving in tunnels is actually twice as safe as driving in the open air, when all factors are taken into account,” says SINTEF scientist Gunnar Jensen. However, a rough estimate suggests that as many as 10 - 20 percent of [...]

Read the rest of this entry »

Okla. Supreme Court Upholds Lower Court Decision Against Antiabortion Ultrasound Law

The Oklahoma Supreme Court has upheld a lower court’s decision that a 2008 state law (SB1878) with several antiabortion provisions is unconstitutional because it covers more than one subject, the Oklahoman reports (Bisbee, Oklahoman, 3/4). The law would have required an ultrasound before an abortion and would limit women’s access to mifepristone, which is used [...]

Read the rest of this entry »

Stupak Renews Abortion Threats In Health Reform

A day after President Obama called for an “up-or-down vote” on health care reform legislation, Rep. Bart Stupak (D-Mich.) said Thursday on ABC’s “Good Morning America” that he and 11 other House members will vote against any final bill that does not include more restrictive language on federal funding for abortion coverage, ABC News reports…

Read the rest of this entry »

OmniComm Introduces TrialOneTM - An Integrated Suite Of Web Based Solutions For Phase I Clinic Automation And Management

OmniComm Systems, Inc. (OTCBB: OMCM), a global provider of eClinical solutions announced that it released TrialOne, a fully integrated, MS .NET, web-based solution designed to automate the Phase I Clinical Trial Process…

Read the rest of this entry »

Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine) Alzheimer’s Disease Clinical Development Program

Pfizer Inc. (NYSE: PFE) and Medivation, Inc. (NASDAQ: MDVN) announced results from two Phase 3 trials of the investigational drug dimebon (latrepirdine*) in patients with Alzheimer’s disease (AD). In the CONNECTION trial, dimebon did not meet its co-primary or secondary efficacy endpoints compared to placebo. Co-primary endpoints were measures of cognition and global function…

Read the rest of this entry »

Rexahn Pharmaceuticals Submits Zoraxel Phase IIb Protocol To FDA

Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, announced that it has submitted a Phase IIb protocol to the FDA for ZoraxelTM for the treatment of erectile dysfunction (ED). “The progression of Zoraxel’s clinical program is very encouraging,” said Rexahn Chief [...]

Read the rest of this entry »

pSivida Reports Presentation Of Additional Positive 24-Month Data From Iluvien(R) Phase 3 FAME™ Study For Diabetic Macular Edema At Angiogenesis

pSivida Corp…

Read the rest of this entry »

Siemens Answers Customers’ Critical Imaging IT Questions At HIMSS 2010

The Imaging & Knowledge Management business unit of Siemens Healthcare will conduct strategic discussions with customers and prospects on utilizing advanced imaging IT software in their healthcare facilities, during the Healthcare Information and Management Systems Society (HIMSS) Annual Meeting, March 1-4, in Atlanta…

Read the rest of this entry »

Children’s Mercy Hospitals And Clinics Installs Toshiba Vascular X-Ray Systems With Next Generation AIP

To bring the latest in cardiovascular X-ray technology to its pediatric patients, Children’s Mercy Hospitals and Clinics in Kansas City, Mo., has installed two InfinixTM CF-i/BP vascular X-ray systems with 8″ x 8″ flat panel detectors (FPD) from Toshiba America Medical Systems, Inc. These systems are the first pediatric bi-plane systems in the U.S…

Read the rest of this entry »

The AACR To Host Second Cancer Research Conference In Jordan

The second American Association for Cancer Research Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic provides attendees with an overview of the most advanced cancer research in a variety of fields, including the tumor microenvironment, microRNAs, signal transduction and novel therapeutic development…

Read the rest of this entry »